Granules India Ltd
NSE:GRANULES

Watchlist Manager
Granules India Ltd Logo
Granules India Ltd
NSE:GRANULES
Watchlist
Price: 559.5 INR 2.69% Market Closed
Market Cap: 135.6B INR
Have any thoughts about
Granules India Ltd?
Write Note

Relative Value

The Relative Value of one GRANULES stock under the Base Case scenario is 690.93 INR. Compared to the current market price of 559.5 INR, Granules India Ltd is Undervalued by 19%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GRANULES Relative Value
Base Case
690.93 INR
Undervaluation 19%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
7
vs Industry
41
Median 3Y
2.1
Median 5Y
2.2
Industry
2.5
Forward
2.6
vs History
3
vs Industry
15
Median 3Y
18
Median 5Y
16.9
Industry
21.9
Forward
22.6
vs History
3
vs Industry
16
Median 3Y
20.8
Median 5Y
18
Industry
16.5
vs History
14
vs Industry
5
Median 3Y
58.7
Median 5Y
60.1
Industry
23.6
vs History
12
vs Industry
19
Median 3Y
3.2
Median 5Y
3.2
Industry
2.1
vs History
7
vs Industry
40
Median 3Y
2.1
Median 5Y
2.2
Industry
2.6
Forward
2.8
vs History
9
vs Industry
41
Median 3Y
4.2
Median 5Y
4.2
Industry
5.2
vs History
3
vs Industry
25
Median 3Y
10.5
Median 5Y
10.5
Industry
13.3
Forward
14.7
vs History
3
vs Industry
23
Median 3Y
13.5
Median 5Y
13.2
Industry
16.6
Forward
16.3
vs History
3
vs Industry
15
Median 3Y
21.9
Median 5Y
19.1
Industry
15.6
vs History
3
vs Industry
2
Median 3Y
44.4
Median 5Y
32.8
Industry
19.1
vs History
14
vs Industry
28
Median 3Y
2.3
Median 5Y
2.4
Industry
1.9

Multiples Across Competitors

GRANULES Competitors Multiples
Granules India Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Granules India Ltd
NSE:GRANULES
135.6B INR 2.9 27.6 15 19.1
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
IN
Granules India Ltd
NSE:GRANULES
Average P/E: 31.8
27.6
132%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top